Search

everythinglearnresearchcommunity

for

Search:↓

The study found that horizontal sections of scalp biopsies are better for analyzing hair loss, showing fewer hairs and more fine hairs in balding areas.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

The Notch signaling pathway helps in mouse hair development through a noncanonical mechanism that does not rely on RBPj or transcription.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Gray hair regained color after thyroid hormone treatment.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.

A woman with an unusual pattern of hair loss was confirmed to have Frontal Fibrosing Alopecia and treated with specific medications.

The report found a new type of hair loss in African-American women that affects more areas of the scalp than previously thought.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Hair loss in lupus patients indicates higher disease activity.

Understanding and treating hair disorders in different ethnic groups requires knowledge of specific hair care practices and hair characteristics.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

Applying a special compound can promote hair growth without harmful side effects.

Understanding hair biology is key to developing better treatments for hair and scalp issues.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Ex vivo dermatoscopy may lower lab costs and improve diagnosis speed for hair loss biopsies.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Hair follicle regeneration may slow tumor growth.

Misdiagnosis of LPP in AGA patients can cause hair transplant issues.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.